KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Change in Acquisitions & Divestments: 2010-2025

Historic Change in Acquisitions & Divestments for Nektar Therapeutics (NKTR) over the last 14 years, with Sep 2025 value amounting to $54.8 million.

  • Nektar Therapeutics' Change in Acquisitions & Divestments fell 15.90% to $54.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $257.8 million, marking a year-over-year decrease of 40.29%. This contributed to the annual value of $340.4 million for FY2024, which is 47.71% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Change in Acquisitions & Divestments of $54.8 million as of Q3 2025, which was down 20.09% from $68.6 million recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Change in Acquisitions & Divestments peaked at $308.8 million during Q2 2021, and registered a low of $54.8 million during Q3 2025.
  • In the last 3 years, Nektar Therapeutics' Change in Acquisitions & Divestments had a median value of $85.6 million in 2024 and averaged $107.6 million.
  • In the last 5 years, Nektar Therapeutics' Change in Acquisitions & Divestments soared by 640.54% in 2021 and then slumped by 63.45% in 2024.
  • Quarterly analysis of 5 years shows Nektar Therapeutics' Change in Acquisitions & Divestments stood at $264.3 million in 2021, then dropped by 24.39% to $199.8 million in 2022, then fell by 21.67% to $156.5 million in 2023, then tumbled by 58.39% to $65.1 million in 2024, then fell by 15.90% to $54.8 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $54.8 million for Q3 2025, versus $68.6 million for Q2 2025 and $69.3 million for Q1 2025.